This company has been acquired
GreenLight Biosciences Holdings Management
Management criteria checks 3/4
GreenLight Biosciences Holdings' CEO is Andrey Zarur, appointed in Aug 2008, they has a tenure of 14.92 years. Their total yearly compensation is $576.56K , comprised of 99.7% salary and 0.3% bonuses, including company stock and options. They directly owns 0.59% of the company’s shares, worth $268.37K. The average tenure of the management team and the board of directors is 1.3 years and 4.4 years respectively.
Key information
Andrey Zarur
Chief executive officer
US$576.6k
Total compensation
CEO salary percentage | 99.7% |
CEO tenure | 14.9yrs |
CEO ownership | 0.6% |
Management average tenure | 1.3yrs |
Board average tenure | 4.4yrs |
Recent management updates
Recent updates
GreenLight Biosciences cutting 25% of staff as part of realignment
Oct 12GreenLight Biosciences launches $109M in financing
Aug 12GreenLight Biosciences, Samsung Biologics complete commercial-scale engineering run for mRNA COVID-19 vaccine
Aug 01GreenLight Biosciences: Synthesizing Cell-Free RNA
Apr 05CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2023 | n/a | n/a | -US$157m |
Dec 31 2022 | US$577k | US$575k | -US$167m |
Sep 30 2022 | n/a | n/a | -US$163m |
Jun 30 2022 | n/a | n/a | -US$154m |
Mar 31 2022 | n/a | n/a | -US$129m |
Dec 31 2021 | US$728k | US$500k | -US$112m |
Sep 30 2021 | n/a | n/a | -US$86m |
Jun 30 2021 | n/a | n/a | -US$89m |
Mar 31 2021 | n/a | n/a | -US$75m |
Dec 31 2020 | US$2m | US$450k | -US$53m |
Compensation vs Market: Andrey's total compensation ($USD576.56K) is about average for companies of similar size in the US market ($USD749.31K).
Compensation vs Earnings: Andrey's compensation has been consistent with company performance over the past year.
CEO
Andrey Zarur (52 yo)
14.9yrs
Tenure
US$576,561
Compensation
Dr. Andrey Juan Zarur, Ph.D. Co-founded GreenLight Biosciences Holdings (aka GreenLight Biosciences, Inc) in 2008 and serves as its President and Chief Executive Officer since August 2008. Dr. Zarur serves...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 14.9yrs | US$576.56k | 0.59% $ 268.4k | |
CFO & Interim Chief Accounting Officer | 4.2yrs | US$1.28m | 0% $ 0 | |
Chief Operating Officer | 7.5yrs | US$1.30m | 0% $ 0 | |
Co-founder and Chief Sustainability & Strategy Officer | less than a year | no data | 0.020% $ 8.9k | |
Chief Technology Officer | 1.3yrs | no data | no data | |
General Counsel | less than a year | no data | no data | |
Senior VP & Head of Corporate Affairs | 2.5yrs | no data | no data | |
Advisor | no data | no data | 0% $ 0 | |
Chief Commercial Officer & General Manager of Plant Health | 2.4yrs | no data | 0% $ 0 | |
Chief Medical Officer | less than a year | no data | no data | |
Chief Business Officer | less than a year | no data | no data | |
Rollover Investor | less than a year | no data | 0.018% $ 8.1k |
1.3yrs
Average Tenure
52yo
Average Age
Experienced Management: GRNA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 14.9yrs | US$576.56k | 0.59% $ 268.4k | |
Independent Director | 4.1yrs | US$293.23k | 0% $ 0 | |
Independent Chairman of the Board | 12.6yrs | US$429.53k | 0.20% $ 91.5k | |
Independent Director | 8.5yrs | US$293.23k | 0% $ 0 | |
Advisor | no data | no data | no data | |
Board Observer | 4.2yrs | no data | no data | |
Independent Director | 5.4yrs | US$293.23k | 0% $ 0 | |
Board Observer | 4.2yrs | no data | no data | |
Board Observer | 4.2yrs | no data | no data | |
Advisor | no data | no data | no data | |
Independent Director | 4.6yrs | US$293.23k | 0.042% $ 19.1k | |
Board Observer | 4.2yrs | no data | no data |
4.4yrs
Average Tenure
57.5yo
Average Age
Experienced Board: GRNA's board of directors are considered experienced (4.4 years average tenure).